Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1963 Sep;22(5):348–353. doi: 10.1136/ard.22.5.348

Nialamide as a “Steroid Sparing” Agent in the Treatment of Rheumatoid Arthritis

V Wright 1,2, W C Walker 1,2, E A M Wood 1,2
PMCID: PMC1030867  PMID: 14059296

Full text

PDF
348

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANGHART H. Effect of marsilid on the symptoms of some of the rheumatic diseases. J Clin Exp Psychopathol. 1958 Apr-Jun;19(2 Suppl 1):114–117. [PubMed] [Google Scholar]
  2. CECCHI E., FERRARIS F. [Preliminary study on the clinical effects of a new monoamine oxidase antagonist in rheumatoid arthritis]. Minerva Med. 1959 Dec 26;50:4455–4456. [PubMed] [Google Scholar]
  3. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  4. HOLDSWORTH C. D., ATKINSON M., GOLDIE W. Hepatitis caused by the newer amine-oxidase-inhibiting drugs. Lancet. 1961 Sep 16;2(7203):621–623. doi: 10.1016/s0140-6736(61)90306-3. [DOI] [PubMed] [Google Scholar]
  5. IKAI M., STEINHAUS A. H. Some factors modifying the expression of human strength. J Appl Physiol. 1961 Jan;16:157–163. doi: 10.1152/jappl.1961.16.1.157. [DOI] [PubMed] [Google Scholar]
  6. KRAMMER F. [The significance of Niamide in the treatment of rheumatic diseases]. Wien Med Wochenschr. 1961 May 27;111:353–355. [PubMed] [Google Scholar]
  7. MICHOTTE L. J. La perturbation de l'homéostase cortisol noradrénaline dans la polyarthrite chronique évolutive. J Belge Med Phys Rhumatol. 1958 May-Jun;13(3):183–189. [PubMed] [Google Scholar]
  8. MORETTI G. F., STAEFFEN J. [A new monoamine oxidase inhibitor: niamide. Its trial in internal medicine]. Sem Med Prof Med Soc. 1961 Mar 20;37:989–991. [PubMed] [Google Scholar]
  9. POPPER H. Pathological findings in jaundice associated with iproniazid therapy. J Am Med Assoc. 1958 Dec 27;168(17):2235–2242. doi: 10.1001/jama.1958.03000170027007. [DOI] [PubMed] [Google Scholar]
  10. PRATESI G., MUZZOLINI M. [Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide]. Minerva Med. 1959 Dec 26;50:4447–4453. [PubMed] [Google Scholar]
  11. SCHERBEL A. L., HARRISON J. W. The effects of iproniazid and other amine oxidase inhibitors in rheumatoid arthritis. Ann N Y Acad Sci. 1959 Sep 17;80:820–834. doi: 10.1111/j.1749-6632.1959.tb49258.x. [DOI] [PubMed] [Google Scholar]
  12. SCHERBEL A. L. The effect of isoniazid and of iproniazid in patients with rheumatoid arthritis. Cleve Clin Q. 1957 Apr;24(2):90–97. doi: 10.3949/ccjm.24.2.90. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES